Robert A. Brown is currently a Senior Director of Peptide Therapeutics at Eli Lilly and Company, having progressed through various roles in the BioTDR Peptide Therapeutics division since 2023. Previously, Robert served as a Research Scientist and Senior Advisor in Peptide Lead Optimization. They completed a PhD in Organic Chemistry at The University of Manchester, following a master's degree from the same institution, and also held an NIH Post Doctoral Research Fellowship in Chemical Biology at the University of Wisconsin-Madison from 2013 to 2017.
Location
Indianapolis, United States
This person is not in any teams
This person is not in any offices